ABSTRACT

One of the most prevalent infections that affect people is urinary tract infection. Uro-pathogenic bacteria, typically Escherichia coli, rise from the perineum into the bladder and overcome host innate immunity to cause simple infections in otherwise healthy women. Patients with abnormalities in the anatomy or function of the urinary tract are at risk of developing complicated infections. The purpose of this study is to assess Duralabhadi Kashaya Ghanavati's antibacterial activity and clinical suitability for treating Mutrakrichha associated with urinary tract infection. By understanding this healthcare providers will be able to provide a range of evidence-based options for managing UTIs, allowing for personalized and holistic care that goes beyond pharmaceutical solutions. 10 diagnosed cases of Mutrakrichha were selected from OPD of Parul Ayurved Hospital between the age group of 18- 40 years. They were administered Duralabhadi Kashaya Ghanavati 2BD after food for 7 days. Subjective parameters like fever, dysuria, frequency, and urgency of urine were assessed as well as objective criterias like urine analysis was also done before and after the treatment. In females with urinary tract infection, Duralabhadi Kashaya Ghanavati was able to promote analgesia, and improvement in urine analysis parameters as well. Keywords: Ayurveda, Mutrakricchra, Urinary Tract Infection, Urogynecology
Publication date: 01/06/2025

https://ijbpas.com/pdf/2025/June/MS_IJBPAS_2025_9084.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2025/14.6.9084